Skip to main content
Fig. 6 | BMC Cardiovascular Disorders

Fig. 6

From: Combining genetic proxies of drug targets and time-to-event analyses from longitudinal observational data to identify target patient populations

Fig. 6

Effect of ABCC8 rs757110 on time to cardiovascular (CV) death/heart transplant from first IHD diagnosis in (a) unmatched and (b) matched participants, and on time to composite outcome – AF hospitalization or CV death/heart transplant from first IHD diagnosis in (c) unmatched diabetic patients and (d) matched diabetic participants. Individuals with AA genotype showed decreased risk of AF hospitalization and CV death/heart transplant composite outcome in pre-diabetic IHD patients compared to those with the CC genotype

Back to article page